dsip peptide side effects risks Benefits & of Therapeutics for Physical & Mental Health dsip peptide side effects safety

The medication has undergone extensive clinical evaluation through the SUSTAIN trials for diabetes and STEP trials for weight management, establishing both efficacy and safety across diverse patient populations

Chang C.H

A larger study (SEMA-NASH) enrolling 320 individuals with obesity, biopsy-proven NASH and different degrees of fibrosis, with or without diabetes, demonstrated that OD subcutaneous semaglutide 0.4 mg significantly resolved MASH without worsening fibrosis in 59% of patients 93

BPC-157 demonstrates unusual stability for a peptide, with activity confirmed via multiple administration routes in rat models[18]